DTIL
Precision BioSciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$157.39M
P/E Ratio
—
EPS
$-2.17
Beta
1.28
52W High
$8.82
52W Low
$3.53
50-Day MA
$7.08
200-Day MA
$5.62
Dividend Yield
—
Profit Margin
-96.70%
Forward P/E
11.78
PEG Ratio
—
About Precision BioSciences Inc
Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States. The company is headquartered in Durham, North Carolina.
Fundamentals
| Revenue (TTM) | $45.07M |
| Gross Profit (TTM) | $45.07M |
| EBITDA | $-37.74M |
| Operating Margin | -83.70% |
| Return on Equity | -70.90% |
| Return on Assets | -18.20% |
| Revenue/Share (TTM) | $2.71 |
| Book Value | $2.95 |
| Price-to-Book | 2.03 |
| Price-to-Sales (TTM) | 3.49 |
| EV/Revenue | 1.416 |
| EV/EBITDA | -0.27 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 37272.00% |
| Shares Outstanding | $25.80M |
| Float | $20.01M |
| % Insiders | 6.44% |
| % Institutions | 65.58% |
Historical Volatility
HV 10-Day
79.93%
HV 20-Day
78.97%
HV 30-Day
70.72%
HV 60-Day
72.04%
HV Rank
67.9%
Volatility is currently expanding
Analyst Ratings
Consensus ($29.60 target)
4
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026